Company Analysis

Aytu BioPharma, Inc. (AYTU)

Nasdaq: AYTU · Pharmaceutical Preparations · Denver, CO · filing with the SEC since 2007
Grade4.2
◀ Past 3.5● Present 5.3▶ Future 3.5
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

27 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Aytu BioPharma, Inc.’s names, not what it holds today.

Patents granted
27
26 utility, 1 design, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
28
since 2001, to Dec 31, 2025
Names they are printed under
5
a subsidiary, a former name, its own name
By yearGrantedApplications published
'09'10'12'13'14'15'16'17'18'19'20'21'22
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Neos Therapeutics, LP a subsidiary
US, as the owner printed on each patent
14 granted
15 published
Aytu BioScience, Inc. a former name
US, as the owner printed on each patent
12 granted
0 published
Aytu BioScience, Inc. a former name
named as the applicant on its applications, in US
0 granted
9 published
Neos Therapeutics, LP a subsidiary
named as the applicant on its applications, in US
0 granted
4 published
AYTU BIOPHARMA, INC. its own name
US, as the owner printed on each patent
1 granted
0 published
Newest grantseach row opens the USPTO’s own copy
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Oct 17, 20192019/0314356Effective Dosing of a Child for the Treatment of ADHD with MethylphenidatePharmaceuticalsNeos Therapeutics, LP · patent 11,166,947 granted from it
Aug 8, 20192019/0240237METHODS OF TESTOSTERONE THERAPYPharmaceuticalsAytu BioScience, Inc.
May 23, 20192019/0154653DETERMINATION OF FERTILITY POTENTIAL FROM THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLEMedical technologyAytu BioScience, Inc. · patent 10,533,986 granted from it
Oct 5, 20172017/0281786COMPOSITIONS AND METHODS OF MAKING RAPIDLY DISSOLVING IONICALLY MASKED FORMULATIONSPharmaceuticalsNeos Therapeutics, LP
Jul 6, 20172017/0191981DETERMINATION OF FERTILITY POTENTIAL FROM THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLEMedical technologyAytu BioScience, Inc. · patent 10,088,466 granted from it
Mar 2, 20172017/0059549METHODS AND SYSTEMS FOR MEASURING AND USING THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLEMeasurementAytu BioScience, Inc. · patent 10,184,931 granted from it
Nov 24, 20162016/0341693MULTIPLE LAYER GELMeasurementAytu BioScience, Inc. · patent 10,281,425 granted from it
Oct 27, 20162016/0313296USE OF ORP FOR CHARACTERIZING STROKE PATIENTSAnalysis of biological materialsAytu BioScience, Inc.
Oct 27, 20162016/0313279METHODS AND SYSTEMS FOR MEASURING AND USING THE OXIDATION-REDUCTION POTENTIAL OF A BIOLOGICAL SAMPLEMeasurementAytu BioScience, Inc.
Oct 6, 20162016/0290960Measurement and Uses of Oxidative StatusMeasurementAytu BioScience, Inc. · patent 10,036,723 granted from it

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton AYTU · research, not advice